Articles tagged with Viral Infections
Immunology researchers at the Babraham Institute discovered how lung tissue is remodelled to support an immune response to influenza, producing antibodies with cross-protection against multiple strains. The findings may lead to more robust seasonal influenza vaccination and new therapeutic strategies for autoimmune diseases.
Research in mice at the University of Tokyo found that heat waves can reduce the body's immune response to flu. However, providing supplemental nutrition before and after infection can help restore normal immune function. The study suggests that food insecurity may weaken the immune system, making people more susceptible to illness.
Researchers have discovered the structure of a virus that infects bacteria thriving in 160-degree hot springs, which could enhance targeted drug delivery and lead to breakthroughs in DNA sequencing technology.
High ambient temperatures reduce food intake, body weight, and immune response in mice infected with viral pathogens like the flu virus and Zika virus. Nutritional supplementation may enhance immune responses to emerging infectious diseases in tropical or developing countries.
A new computational method called CATCH enables scientists to design molecular probes that can capture genetic material of various microbes, including viruses. This approach has been successfully tested in detecting low-abundance viruses like Zika, improving the detection of viral content in clinical samples.
Researchers have developed a new optofluidic chip-based test to detect Zika virus, which can identify the stage of infection and guide treatment. The technology has the potential to pinpoint recent infections and predict disease progression.
A Phase 1 clinical trial is underway at Cincinnati Children's Hospital Medical Center to test two experimental Ebola vaccines, ChAd3-EBO-Z and MVA-BN-Filo, for their safety and ability to produce an immune response. The trial aims to enroll up to 60 healthy volunteers between 18-45 years of age.
A comprehensive package of interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030. Implementing comprehensive blood safety and infection control measures was estimated to reduce the number of new infections in 2030 by 58%.
A study published in PLOS Pathogens suggests that CD4+ T cells are essential for local control of viral infection and can confer protection against lethal doses of the Zika virus. The findings support the development of vaccines targeting this cell type, which may be safe and effective against infection in multiple contexts.
Researchers found genetic material and antibodies from the virus in a Greater Long-fingered bat in Liberia's Nimba District. The discovery adds to evidence suggesting bats serve as natural wildlife reservoirs for Ebola and other related viruses, shedding light on how outbreaks occur.
Researchers at the University of East Anglia have confirmed cases of RHDV2 in UK hares, contributing to a decline of over 80% in brown hare populations due to agricultural changes. The expanding dataset will help map reported mortalities over time and identify primary causes of the die-off.
A recent study found that needle and syringe programs are a cost-effective way to prevent hepatitis C (HCV) transmission among people who inject drugs. The research, funded by the National Institute for Health Research, estimated that these programs would save millions of pounds in infection treatment costs in the UK. In addition to re...
A 15-year study found a significant increase in US liver transplants for alcohol-associated liver disease, but with lower five-year survival rates compared to other liver conditions. The study suggests changing attitudes towards sobriety length may be driving this trend.
Researchers found that prior and recent dengue virus infection was associated with protection from symptomatic Zika virus infection in a pediatric cohort. However, previous exposure did not affect the rate of total Zika virus infection. The study suggests that prior dengue virus immunity might cross-protect against symptomatic Zika.
Researchers found that prior dengue exposure protects children from symptomatic Zika disease in the Americas. Children with a prior dengue infection were 38% less likely to develop symptomatic Zika than those without prior exposure. This suggests an immunological interaction between dengue and Zika viruses.
A new study found that prior dengue virus infection in children may be protective against symptomatic Zika virus infection. The research, published in PLOS Medicine, involved over 3,000 children aged 2-14 years and showed that those with a history of dengue infection had a lower risk of being symptomatic when infected with Zika.
A team of researchers at Texas Biomed has identified the interaction between an Ebola virus protein and a human cell protein that may be crucial to understanding the virus's life cycle. By studying this interaction in human cells using live virus, the scientists hope to develop potential drug targets to stop the disease.
Bronchiolitis, a common viral lung infection, is often treated with antibiotics in US emergency rooms, contradicting evidence-based guidelines. The study found that 25% of children under 2 years old with bronchiolitis received antibiotics between 2007 and 2015.
Scientists warn of increased bluetongue risk in the UK due to climate change, with larger outbreaks predicted under warmer conditions. Existing control measures can still prevent largest outbreaks, but ongoing vigilance is crucial.
Researchers sequenced the European gypsy moth genome, revealing its largest moth or butterfly genome ever recorded. The study provides insights into the insect's immune system and potential bioinsecticides to protect forests and orchards from destruction.
Researchers studied dengue virus fusion peptide structures, revealing a hydrophobic region and polar 'collar' crucial for cell membrane fusion. This review aims to expand knowledge on the mechanism of virus infection, potentially leading to new inhibition methods.
Scientists have developed a combination of monoclonal antibodies that protect animals from all three Ebola viruses, known to cause human disease. The experimental treatment, called MBP134, has shown broad protective efficacy in both animal models and large animal models.
The Madariaga virus has been identified in eight children in Haiti, with symptoms resembling dengue fever infection. Researchers suggest the virus was introduced to Haiti from Panama between 2012 and 2015, raising concerns about its potential spread to other Caribbean or North American regions.
Researchers found that lethal disease can occur without viral replication in EHEC-infected mice. The study suggests potential novel treatments for EHEC and life-threatening kidney complications in children.
A study found that NPY enhances pulmonary inflammation and viral replication in severe influenza virus infection, leading to poorer outcomes. Deletion of NPY improved survival rates and reduced disease pathology in infected mice.
A team of researchers analyzed the immune system of P. aeruginosa in cystic fibrosis patients, finding diverse bacterial populations with varying responses to viruses. The study's findings have implications for phage therapy and understanding infectious disease.
Researchers have identified a new genus of filovirus from a Rousettus bat in China, which shares genetic similarities with Ebola and Marburg viruses. The M?nglà virus poses a potential risk of interspecies transmission and has only been detected in bats so far.
USC scientists have made groundbreaking discoveries about a tick-borne virus, including its molecular mechanisms and potential therapeutic targets. The research could lead to the development of medications and a vaccine to prevent or treat hemorrhagic fever.
Researchers used metagenomic nanopore sequencing to analyze 120 Lassa virus samples, implicating rodent contamination as the main driver of the outbreak. The technology provided rapid, real-time characterization of the pathogen, allowing for prompt public health responses and alleviating concerns about novel strains.
Hepatitis C infection affects 0.93% of US adults, with highest rates in opioid crisis-affected states, and varies by state and region
Researchers at Cornell University have developed a low-cost method to capture complete RNA transcription information in single-cell genomics. The new technique, called DART-seq, uses droplet microfluidics to simultaneously analyze multiple genes and identify virus-infected cells.
Researchers at Technical University of Munich discovered that immune cells attacking liver sinusoidal endothelial cells disrupts the organ's blood and nutrient supply, leading to overwhelming damage. A new perforin inhibitor agent has been identified to prevent this lethal process.
A new microneedle patch vaccine containing the inactivated RSV virus has been shown to be effective in enhancing protection against the disease and reducing inflammation. The vaccine, combined with an immune-stimulating compound, was found to induce a stronger immune response than traditional intramuscular vaccination.
Researchers discovered shared and virus-specific mechanisms used by dengue and Zika viruses to counteract human and mosquito immune defense, hijack host proteins, and disrupt brain development. They found that Zika virus causes microcephaly in fruit flies by disrupting the function of ANKLE2 protein.
Researchers identified a new interaction between the Ebola virus protein VP30 and human host protein RBBP6, which disrupts virus growth. The study provides potential therapeutic targets for treating Ebola virus infections.
Researchers discovered a human protein, RBBP6, that interferes with the Ebola virus replication cycle. By mimicking this protein's function, a small molecule drug could potentially block Ebola virus infection in human cells.
A lab study identified key ways the three viruses hijack human cells and found at least one potential drug that can disrupt this process in human cells. Researchers also discovered how the Zika virus might cause microcephaly in infants, a crucial step towards developing a treatment.
A recent study by RUDN medics revealed critical spread rates of five types of viral hepatitis in Somalia, with 18.9% of residents infected with hepatitis B and higher rates for hepatitis A and E. The researchers emphasize the need for immediate action to address this global health crisis.
A team from Osaka University has created a system to produce large numbers of human norovirus particles using intestinal epithelial cells derived from human induced pluripotent stem cells. This breakthrough allows for the study of the virus and potential vaccine development without relying on human tissue or bile.
Scientists at Imperial College London discovered that persister cells manipulate immune cells, potentially opening new avenues to clearing these cells from the body. The study found that persisters weaken the power of macrophages, a key part of our arsenal against infection.
Research suggests that distinct HIV-1 strains differ in their interaction with CCR5 molecules, affecting cell infectability and entry efficacy. The study found that the nature of these receptor interactions regulates viral properties and has potential implications for developing targeted therapies.
Scientists discovered Mycobacterium tuberculosis releases RNA into infected cells, stimulating interferon beta production to support pathogen growth. Mice lacking key protein required for responding to foreign RNA were better able to control MTB infection.
A new study has found that Rift Valley fever virus can cause high rates of stillbirth in pregnant rats and human tissue, with the virus evading the mother-child barrier more efficiently than other vertically transmitted viruses. The research aims to develop vaccines to prevent the virus from causing miscarriage and birth defects.
A recent study published in Nature Immunology reveals that lung-resident memory B cells can provide more effective immunity against influenza infections. These cells are able to respond quickly and produce antibodies after a second infection, suggesting they play a crucial role in respiratory virus immunity.
Researchers at the University of Hawaii have developed a recombinant subunit vaccine that uses only a small part of the Zika virus to protect against infection. The vaccine has shown efficacy in both mice and monkeys, providing an important milestone in its development.
Researchers developed nanoparticles that detect proteases produced by bacteria and immune cells, allowing for faster diagnosis of pneumonia. The sensors can indicate whether antibiotics are effective in treating the infection.
Researchers have generated six Zika virus antibodies that could be used to diagnose and potentially treat the mosquito-borne disease. The neutralizing property of these antibodies prevents the virus from infecting cells, rendering it harmless.
Researchers from Technical University of Munich identified a previously unknown virus causing mass mortality in brown trout. The piscine reovirus is related to the virus infecting salmon in North Atlantic and Pacific, causing significant economic damage.
Researchers analyzed severe influenza cases in Catalan hospitals to study vaccination effectiveness in reducing ICU admissions and deaths. Vaccination showed 23% effectiveness overall, with 44% for those over 65.
Researchers found that specific sugars in breast milk enhance infection of cells with a particular strain of rotavirus, leading to gastrointestinal symptoms in newborns. The study also identifies maternal components that could improve the performance of live, attenuated rotavirus vaccines.
Researchers found that protocadherin-1 (PCDH1) is essential for hantavirus infection of lung cells. Disrupting this recognition event could lead to a therapeutic against hantavirus pulmonary syndrome (HPS). The study, supported by NIH funding, used monoclonal antibodies to block virus entry and showed promising results in hamster models.
A global team of investigators has identified protocadherin-1 (PCDH1) as a crucial protein involved in Hantavirus Pulmonary Syndrome (HPS), a serious respiratory disease. The study, published in Nature, reveals that PCDH1 facilitates lung cell infection and triggers HPS, providing a viable target for blocking the disease.
Researchers identified protocadherin-1 as a key receptor facilitating hantavirus lung cell entry. Deleting this receptor made lab animals resistant to infection, offering potential therapeutic strategy against hantavirus pulmonary syndrome.
Researchers isolated antibodies from human survivors of Andes hantavirus infection that protected hamsters against the deadly disease. The antibodies shielded animals even after administration, suggesting they could be used as a preventative treatment for hantavirus cardiopulmonary syndrome.
Researchers developed a model predicting animal viruses capable of spreading among humans, highlighting potential targets for disease surveillance. The study identified 47 viruses with high transmissibility potential, including Carnivore amdoparvovirus 1 and Simian Foamy virus.
Research suggests that frogs from virus-exposed groups are breeding at significantly younger ages than those in disease-free populations. This decrease in breeding age poses a risk of local extinction due to environmental changes.
Scientists have discovered evidence of infectious prions in the eyes of deceased Creutzfeldt-Jakob disease (CJD) patients, which could lead to early diagnosis and treatment of this fatal neurodegenerative disease. The finding raises concerns about the safety of routine eye exams and corneal transplants.
A new study of disease transmission in bats has quantified unseen interactions that play a crucial role in the spread of disease through populations and between species. The researchers found that infrequent and indirect connections among individuals are far more important in disease transmission than previously thought.
Researchers at Griffith University have discovered specific sugar molecules that bind to the respiratory tract, allowing influenza viruses like H5N1 to infect humans. This knowledge could lead to the development of novel anti-influenza drugs to prevent human infection.
The FluChip-8G test promises to reduce influenza A and B characterization times from two weeks to eight hours. The study uses the test alongside standardized WHO/CDC rRT-PCR tests, employing specimens collected from various locations including Vietnam, Malaysia, and the US.